A detailed history of Ns Partners LTD transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ns Partners LTD holds 204,471 shares of EW stock, worth $13.6 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
204,471
Previous 203,715 0.37%
Holding current value
$13.6 Million
Previous $19.5 Million 2.98%
% of portfolio
0.86%
Previous 0.9%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$84.3 - $94.31 $63,730 - $71,298
756 Added 0.37%
204,471 $18.9 Million
Q1 2024

May 09, 2024

SELL
$72.54 - $95.56 $292,118 - $384,820
-4,027 Reduced 1.94%
203,715 $19.5 Million
Q4 2023

Feb 09, 2024

BUY
$61.71 - $77.76 $21,721 - $27,371
352 Added 0.17%
207,742 $15.8 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $41,775 - $56,308
-603 Reduced 0.29%
207,390 $14.4 Million
Q2 2023

Aug 10, 2023

SELL
$81.41 - $94.33 $124,638 - $144,419
-1,531 Reduced 0.73%
207,993 $19.6 Million
Q1 2023

May 10, 2023

BUY
$74.26 - $84.51 $29,852 - $33,973
402 Added 0.19%
209,524 $17.3 Million
Q4 2022

Feb 10, 2023

BUY
$68.3 - $87.44 $910,712 - $1.17 Million
13,334 Added 6.81%
209,122 $15.6 Million
Q3 2022

Nov 10, 2022

SELL
$82.37 - $107.29 $2.2 Million - $2.87 Million
-26,723 Reduced 12.01%
195,788 $16.2 Million
Q2 2022

Aug 05, 2022

BUY
$86.5 - $128.27 $3.12 Million - $4.63 Million
36,099 Added 19.37%
222,511 $21.2 Million
Q1 2022

May 12, 2022

SELL
$101.96 - $128.34 $764,292 - $962,036
-7,496 Reduced 3.87%
186,412 $21.9 Million
Q4 2021

Feb 10, 2022

BUY
$106.37 - $130.68 $65,736 - $80,760
618 Added 0.32%
193,908 $25.1 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $88,605 - $105,687
861 Added 0.45%
193,290 $21.9 Million
Q2 2021

Aug 02, 2021

BUY
$83.84 - $104.76 $60,532 - $75,636
722 Added 0.38%
192,429 $19.9 Million
Q1 2021

Apr 30, 2021

SELL
$78.68 - $90.67 $613,861 - $707,407
-7,802 Reduced 3.91%
191,707 $16 Million
Q4 2020

Feb 10, 2021

BUY
$71.69 - $91.23 $139,365 - $177,351
1,944 Added 0.98%
199,509 $18.2 Million
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $528,516 - $687,803
7,866 Added 4.15%
197,565 $15.8 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $7.3 Million - $9.76 Million
126,804 Added 201.61%
189,699 $13.1 Million
Q1 2020

May 13, 2020

BUY
$52.41 - $81.0 $1 Million - $1.55 Million
19,091 Added 43.58%
62,895 $11.9 Million
Q4 2019

Feb 12, 2020

SELL
$71.7 - $82.09 $788 - $902
-11 Reduced 0.03%
43,804 $10.2 Million
Q3 2019

Nov 13, 2019

BUY
$61.55 - $75.43 $77,676 - $95,192
1,262 Added 2.97%
43,815 $9.64 Million
Q2 2019

Aug 07, 2019

BUY
$55.74 - $64.41 $472,842 - $546,390
8,483 Added 24.9%
42,553 $7.86 Million
Q4 2018

Feb 12, 2019

BUY
$46.41 - $56.94 $456,906 - $560,574
9,845 Added 40.64%
34,070 $5.22 Million
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $1.11 Million - $1.41 Million
24,225 New
24,225 $4.22 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Ns Partners LTD Portfolio

Follow Ns Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ns Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ns Partners LTD with notifications on news.